-
EUR RADIOL 2019 10.1007/s00330-018-5993-y
Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival
Lee1, DH; Lee, JM; Kim, PN; Jang, YJ; Kang, TW; Rhim, H; Seo, JW; Lee, YJ
View PubMed
-
Abdom Radiol (NY) 2019 10.1007/s00261-019-01952-1
Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy
Kim1, W; Cho, SK; Shin, SW; Hyun, D; Lee, MW; Rhim, H
View PubMed
-
ACTA RADIOL 2019 10.1177/0284185119842830
Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension
Kim1, R; Jeong, WK; Kang, TW; Song, KD; Lee, MW; Ahn, SH; Rhim, H
View PubMed
-
EUR RADIOL 2019 10.1007/s00330-018-5868-2
Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure
Cha1, DI; Kang, TW; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Kim, K
View PubMed
-
WORLD J GASTROINTEST ONCOL 2019 10.4251/wjgo.v11.i3.227
Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm
Song1, KD; Lim, HK; Rhim, H; Lee, MW; Kang, TW; Paik, YH; Kim, JM; Joh, JW
View PubMed
